Patents by Inventor Joel D. Enas

Joel D. Enas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9102950
    Abstract: The disclosure provides adjuvants, immunogenic compositions, and methods useful for vaccination and immune response. In particular, the disclosure provides a class of adjuvants comprising cationic lipid:co-lipid mixtures and methods for delivering formulated compositions.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 11, 2015
    Assignee: Vical Incorporated
    Inventors: Jukka Hartikka, Sean M. Sullivan, Joel D. Enas, Alain P. Rolland
  • Patent number: 8999345
    Abstract: The disclosure provides adjuvants, immunogenic compositions, and methods useful for vaccination and immune response. In particular, the disclosure provides a class of adjuvants comprising cationic lipid:co-lipid mixtures and methods for delivering formulated compositions.
    Type: Grant
    Filed: August 3, 2012
    Date of Patent: April 7, 2015
    Assignee: Vical Incorporated
    Inventors: Jukka Hartikka, Sean M. Sullivan, Joel D. Enas, Alain Rolland
  • Publication number: 20130045222
    Abstract: The disclosure provides adjuvants, immunogenic compositions, and methods useful for vaccination and immune response. In particular, the disclosure provides a class of adjuvants comprising cationic lipid:co-lipid mixtures and methods for delivering formulated compositions.
    Type: Application
    Filed: August 3, 2012
    Publication date: February 21, 2013
    Applicant: Vical Incorporated
    Inventors: Jukka Hartikka, Sean M. Sullivan, Joel D. Enas, Alain Rolland
  • Publication number: 20120014976
    Abstract: The disclosure provides adjuvants, immunogenic compositions, and methods useful for vaccination and immune response. In particular, the disclosure provides a class of adjuvants comprising cationic lipid:co-lipid mixtures and methods for delivering formulated compositions.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 19, 2012
    Applicant: Vical Incorporated
    Inventors: Jukka Hartikka, Sean M. Sullivan, Joel D. Enas, Alain Rolland
  • Publication number: 20090191227
    Abstract: The disclosure provides adjuvants, immunogenic compositions, and methods useful for vaccination and immune response. In particular, the disclosure provides a class of adjuvants comprising cationic lipid:co-lipid mixtures and methods for delivering formulated compositions.
    Type: Application
    Filed: May 23, 2008
    Publication date: July 30, 2009
    Applicant: Vical Incorporated
    Inventors: Jukka Hartikka, Sean M. Sullivan, Joel D. Enas, Alain Rolland
  • Patent number: 5372813
    Abstract: Disclosed is a substituted 6-nitroquipazine of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are each selected from the group consisting of H, Fl, CL, Br, I, CF.sub.3, CH.sub.2 CH.sub.2 F, CH.sub.3, CH.sub.2 CH.sub.3, and --CH(CH.sub.3).sub.2, and wherein one of R.sub.1, R.sub.2, R.sub.3, and R.sub.4 is other than H.Also disclosed is a method for measurement of serotonin uptake sites in a sample, in which a radioligand is incubated with a sample and then the radioactivity of the radioligand bound to the sample is determined, utilizing a radio labeled substituted 6-nitroquipazine as the radioligand. Also disclosed is a method of manufacture and method of use.
    Type: Grant
    Filed: December 22, 1992
    Date of Patent: December 13, 1994
    Assignee: The Regents, University of California
    Inventors: Chester A. Mathis, Jr., Anat Biegon, Scott E. Taylor, Joel D. Enas